| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |